Stargardt Disease Stgd1 clinical trials

Explore recruiting stargardt disease stgd1 clinical trials.

Recruiting stargardt disease stgd1 studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Stargardt Disease Stgd1 trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

An Open-label, Multicenter, Two Part, Ascending Dose Followed by a Controlled Trial to Assess the Safety and Efficacy of a Subretinal Administration of AAVB-039 in Participants with Stargardt Disease (STGD1) (CELESTE)

Belgium, Italy, Netherlands, Norway

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A Phase 1/2, First-in-Human, Open-label, Assessor-Masked, Randomized, Controlled, Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects with Stargardt Disease (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ATP Binding Cassette Subfamily A Member 4 (ABCA4) Gene (ASTRA).

Germany, Belgium

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Stargardt Disease Stgd1 trials by city

Stargardt Disease Stgd1 in Toronto Stargardt Disease Stgd1 in Vancouver Stargardt Disease Stgd1 in Montreal Stargardt Disease Stgd1 in Calgary Stargardt Disease Stgd1 in Edmonton Stargardt Disease Stgd1 in Ottawa Stargardt Disease Stgd1 in Winnipeg Stargardt Disease Stgd1 in Quebec City Stargardt Disease Stgd1 in Hamilton Stargardt Disease Stgd1 in Kitchener Stargardt Disease Stgd1 in London Stargardt Disease Stgd1 in Halifax Stargardt Disease Stgd1 in New York Stargardt Disease Stgd1 in Los Angeles Stargardt Disease Stgd1 in Chicago Stargardt Disease Stgd1 in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease